Ping An Reports Steady 7.6% Growth in Operating Profit Attributable to Shareholders of the Parent Company in Q1 2026, Life & Health NBV Increases 20.8% YoY
Group Total Assets Exceed RMB14 Trillion HONG KONG and SHANGHAI, April 28, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group"; HKEX: 2318; SSE: 601318) today announced its first quarter...
The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease
PARIS, April 27, 2026 /PRNewswire/ -- A new study has established that treatment with essential phospholipids (Essentiale) resulted in a 2.5 times greater reduction in liver fat, significant improvement in fatigue and improvement of glycaemic...
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
SAN DIEGO, April 20, 2026 /PRNewswire/ -- Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ABO2203 in patients with relapsed/refractory...
First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
SHANGHAI, April 8, 2026 /PRNewswire/ -- On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The...
GameChange Solar Announces Successful Industry-First, Full-Scale Seismic Testing of Single-Axis Solar Trackers
Genius Tracker™ system completes IEEE 693 high-performance level earthquake testing at UC Berkeley's PEER Lab NORWALK, Conn., March 31, 2026 /PRNewswire/ -- GameChange Solar, a leading global supplier of solar tracker and fixed-tilt racking...
"First-listed Chinese Noodle Restaurant" Xiao Noodles Announces 2025 Annual Results
Achieving Dual Success in Scale and Profitability, with a Substantial Increase in Annual Profit Performance Highlights: Revenue: RMB1,622.4 million, representing a year-on-year increase of 40.5% Net Profit: RMB106.1 million, representing a...
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven...
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
HAMILTON, ON, Feb. 24, 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first patient in Radiopharm Theranostics' First-in-Human Phase...
First "Global Fertility Crisis Forum" Brings Together Experts to Tackle Low Birth Rate Challenges
HONG KONG, Jan. 26, 2026 /PRNewswire/ -- The inaugural 2026 Global Fertility Crisis Forum was held last Thursday in Hong Kong. The event brought together 44 guests from more than ten countries and regions, including representatives from the United...
Rokid Launches the World's First Open AI Ecosystem Smart Glasses -- Ultra-Light, Prescription-First, and Built to Work with ChatGPT, Qwen, DeepSeek, and More
A 38.5-gram, display-free AI glasses platform featuring a dual-chip architecture and global accessibility focus—bringing AI into everyday wear and accelerating the mainstream adoption of smart eyewear. LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- Rokid ,...